Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

NKTX

Nkarta (NKTX)

Nkarta Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:NKTX
DateTimeSourceHeadlineSymbolCompany
05/12/202422:01GlobeNewswire Inc.Nkarta Announces IND Clearance of Investigator-Sponsored Trial in Myasthenia Gravis and Opening of Enrollment for Ntrust-2NASDAQ:NKTXNkarta Inc
26/11/202423:02GlobeNewswire Inc.Nkarta to Participate in an Upcoming Investor ConferenceNASDAQ:NKTXNkarta Inc
15/11/202408:05Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:NKTXNkarta Inc
13/11/202400:02GlobeNewswire Inc.Nkarta to Participate in an Upcoming Investor ConferenceNASDAQ:NKTXNkarta Inc
09/11/202406:17Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:NKTXNkarta Inc
08/11/202408:21Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:NKTXNkarta Inc
08/11/202408:11Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NKTXNkarta Inc
08/11/202408:02GlobeNewswire Inc.Nkarta Reports Third Quarter 2024 Financial Results and Corporate HighlightsNASDAQ:NKTXNkarta Inc
26/10/202412:44Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:NKTXNkarta Inc
26/10/202412:44Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:NKTXNkarta Inc
04/09/202406:01GlobeNewswire Inc.Nkarta to Participate in Upcoming Investor ConferenceNASDAQ:NKTXNkarta Inc
24/08/202406:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NKTXNkarta Inc
14/08/202411:03GlobeNewswire Inc.Correction: Nkarta Reports Second Quarter 2024 Financial Results and Corporate HighlightsNASDAQ:NKTXNkarta Inc
14/08/202406:08Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:NKTXNkarta Inc
14/08/202406:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NKTXNkarta Inc
14/08/202406:01GlobeNewswire Inc.Nkarta Reports Second Quarter 2024 Financial Results and Corporate HighlightsNASDAQ:NKTXNkarta Inc
01/08/202406:48Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NKTXNkarta Inc
01/08/202406:47Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:NKTXNkarta Inc
01/08/202406:45Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NKTXNkarta Inc
24/07/202420:00GlobeNewswire Inc.Nkarta Announces Initiation of Investigator-Sponsored Clinical Trial Evaluating NKX019 for Systemic Lupus ErythematosusNASDAQ:NKTXNkarta Inc
16/07/202420:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NKTXNkarta Inc
16/07/202420:01GlobeNewswire Inc.Nkarta Announces Leadership Updates, Appoints Nadir Mahmood as PresidentNASDAQ:NKTXNkarta Inc
27/06/202420:00GlobeNewswire Inc.Nkarta Initiates Clinical Trial of NKX019 in Lupus Nephritis with First Patient in Screening and Announces Pipeline Expansion to Additional Autoimmune IndicationsNASDAQ:NKTXNkarta Inc
15/06/202406:10Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NKTXNkarta Inc
15/06/202406:07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NKTXNkarta Inc
15/06/202406:07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NKTXNkarta Inc
15/06/202406:04Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:NKTXNkarta Inc
14/06/202406:22Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NKTXNkarta Inc
14/06/202406:01GlobeNewswire Inc.Nkarta Adds Experienced Leader in Autoimmune R&D, George Vratsanos, M.D., FACR, to Board of DirectorsNASDAQ:NKTXNkarta Inc
10/05/202406:14Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:NKTXNkarta Inc
 Showing the most relevant articles for your search:NASDAQ:NKTX